Vertex passes key test in quest to treat kidney diseases

7 hours ago

FDA approves leucovorin as first drug for rare genetic disorder

7 hours ago

Hims & Hers shares surge after Novo Nordisk drops patent infringement case

9 hours ago

Inside the booming business of wellness third spaces and membership clubs

3 days ago

FDA vaccine head will step down in April after string of controversial decisions

4 days ago

FDA reversals leave investors worrying about the fates of other experimental drugs

4 days ago

FDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's

4 days ago

We're dipping into our large cash pile to buy more of this health-care stock

5 days ago

Eli Lilly launches program to boost employer coverage of obesity drugs in U.S.

5 days ago

Decades into cystic fibrosis fight, Boomer Esiason and son Gunnar are winning

5 days ago

We've been active with trades during the Iran war fallout. Cramer explains our approach

6 days ago

Here's Jim Cramer's advice for navigating the markets during the Iran conflict

8 days ago

Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly

8 days ago

How the 'K-shaped' economy is showing up at two big U.S. gyms

10 days ago

A rapid-fire update on our 4th Industrial Revolution stocks and our other names

10 days ago

We're adding a stock to our Bullpen that is resistant to recessions, AI disruption

11 days ago

Trump angering MAHA with glyphosate order gives Democrats an opening

11 days ago

Novartis, Genentech file suit alleging illegal importation of prescription drug

12 days ago

Healthy Returns: What's next for Novo Nordisk's next obesity drug CagriSema

12 days ago

Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%

14 days ago

Eli Lilly launches new form of Zepbound with a month of doses in one pen

14 days ago

Novo Nordisk down 15% after weight loss drug fails to match Eli Lilly's in trial

15 days ago

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

19 days ago

Kennedy defends Trump glyphosate order as MAHA erupts

19 days ago

FDA chief calls for reforms as U.S. loses ground to China in early drug trials

19 days ago

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

20 days ago

FDA chief Marty Makary says more drugs should be available over the counter

20 days ago

Danaher is tapping the M&A well yet again. But we might have had enough

21 days ago

French prosecutors investigate Nestle, Danone over contaminated baby formula

21 days ago

Novo Nordisk faces a defining year in the obesity drug market

22 days ago

How largest health-care education company in U.S. is tackling growing jobs gap

27 days ago

Novo CEO sees 15 million patient opportunity in Medicare obesity coverage

27 days ago